Hepatitis C: Epidemiology, diagnosis, and management

Comprehensive Therapy

Volumn 33, Issue 2, 2007, Pages 87-93

  Itskowitz, Marc S ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTACID AGENT; ANTISENSE OLIGONUCLEOTIDE; HERBACEOUS AGENT; INTERFERON; PARACETAMOL; PEGINTERFERON; PLACEBO; PROTEINASE INHIBITOR; RIBAVIRIN; SILYBUM MARIANUM EXTRACT;

BLOOD TRANSFUSION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CYTOPENIA; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEVER; FLU LIKE SYNDROME; HEADACHE; HEMODIALYSIS; HEMOLYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; INSOMNIA; LABORATORY TEST; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MONOTHERAPY; MORBIDITY; MYALGIA; NAUSEA; PRURITUS; RASH; REVIEW; RIBOZYME THERAPY; RISK FACTOR; SERODIAGNOSIS; SEXUAL BEHAVIOR; UNSPECIFIED SIDE EFFECT; VIRUS CULTURE; VIRUS TRANSMISSION;

HEPATITIS C; HUMANS;

EID: 36949026907     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12019-007-8005-8     Document Type: Review

References (21)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
2. McQuillan GM, et al. A population based serologic study of hepatitis C virus infection in the United States. In: Rizzetto M, et al., editors. Viral hepatitis and liver disease. Torino: Edizioni Minerva Medica; 1997.
3. Alter MJ, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556.
4. Lauer GM, Walker BD. Hepatitis c virus infection. N Engl J Med 2001;345(1):41.
5. Hernandez ME, Bruguera M, Puyuelo T, Barrera JM, Sanchez Tapias JM, Rodes J. Risk of needle-stick injuries in the transmission of hepatitis C virus in hospital personnel. J Hepatol 1992;16:56-8.
6. Thomas DL, Villano SA, Riester KA, et al. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers: Women and Infants Transmission Study. J Infect Dis 1998;177:1480-8.
7. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002;36:S21-9.
8. Poynard T, et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825.
9. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995;15:41-63.
10. Flamm SL. Chronic hepatitis c virus infection. JAMA 2003;289(18):2413.
11. Kleiner DE. The liver biopsy in chronic hepatitis C: a view from the other side of the microscope. Semin Liver Dis 2005;25:52-64.
12. Bacon BR. Treatment of patients with hepatitis C and normal serum aminotransferase levels. Hepatology 2002;36(Suppl 1):S179-84.
13. McHutchison JG, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485.
14. Seef LB, Hoofnagle JH. National Institutes of Health consensus development conference: management of hepatitis C: 2002. Hepatology 2002;36(Suppl 1):S1.
15. Poynard T, et al. Randomized trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998;352:1426.
16. Hoofnagle JH, Seeff LB. Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med 2006;355:2444-51.
17. Brok J, Gluud LL, Gluud C. Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials. Am J Gastroenterol 2006;101:842-7.
18. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001;33:562-9.
19. Jacobs BP, et al. Milk thistle for the treatment of liver disease. Am J Med 2002;113:506.
20. Liu JP, et al. Medicinal herbs for hepatitis C virus infection. Cochrane Database Syst Rev 2001;CD003183. Abstract available at: http://www.cochrane.org/ reviews/en/ab003183.html. Accessed June 16, 2004.
21. Alter MJ, Margolis HS. Recommendation for prevention and control of hepatitis C virus infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998;47(RR-19):1.